Diamedica Therapeutics Share Price (NASDAQ: DMAC)
$5.72
Last updated on
Check the interactive Diamedica Therapeutics Stock chart to analyse performance
Diamedica Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$5.60Today's High:$5.86
2.1%
Downside
Day's Volatility :4.36%
Upside
2.31%
- 52 Weeks Low:$3.1952 Weeks High:$6.82
44.23%
Downside
52 Weeks Volatility :53.21%
Upside
16.11%
Diamedica Therapeutics Stock Returns
Diamedica Therapeutics Inc Key Stats
Check Diamedica Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Diamedica Therapeutics Stock including INR - Dollar returns
The Diamedica Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Diamedica Therapeutics investment value today
Current value as on today
₹1,50,831
Returns
₹50,831
(+50.83%)
Returns from Diamedica Therapeutics Stock
₹45,547 (+45.55%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Diamedica Therapeutics Stock
Global Institutional Holdings in Diamedica Therapeutics Inc
Name
Holdings %
Cooperman Leon G
3.20%
Vanguard Group Inc
2.98%
First Manhattan Co. LLC
1.18%
PARAGON Assoc & PARAGON Assoc II JV
1.17%
Susquehanna International Group, LLP
1.08%
Bleichroeder LP
0.74%
Analyst Recommendation on Diamedica Therapeutics Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Diamedica Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Diamedica Therapeutics Share Price Target
What analysts predicted
Upside of 115.62%
Target:
$12.33
Current:
$5.72
Diamedica Therapeutics share price target is $12.33, a slight Upside of 115.62% compared to current price of $5.72 as per analysts' prediction.
Diamedica Therapeutics Stock Insights
Price Movement
In the last 7 days, DMAC stock has moved down by -6.4%Decreasing Revenue
Revenue is down for the last 2 quarters, 30.83M → 13.80M (in $), with an average decrease of 55.2% per quarterIncreasing Net Profit
Netprofit is up for the last 3 quarters, -7.9M → -7.69M (in $), with an average increase of 1.3% per quarterDMAC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 24.4%
Diamedica Therapeutics Technicals Summary
Sell
Neutral
Buy
Diamedica Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Diamedica Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 38.83% | -7.89% | 47.04% | 225.0% | 22.22% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.68 | -0.73 | -0.45 | NA | 0.63 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $309.1M | 22.22% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Diamedica Therapeutics Inc
Key Management of Diamedica Therapeutics Inc
Important FAQs about investing in DMAC Stock from India :
What is Diamedica Therapeutics share price today?
Diamedica Therapeutics share price today is $5.72 as on at the close of the market. Diamedica Therapeutics share today touched a day high of $5.86 and a low of $5.60.
What is the 52 week high and 52 week low for Diamedica Therapeutics share?
Diamedica Therapeutics share touched a 52 week high of $6.82 and a 52 week low of $3.19. Diamedica Therapeutics stock price today i.e. is closed at $5.72, lower by 16.11% versus the 52 week high.
How to invest in Diamedica Therapeutics Stock (DMAC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Diamedica Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Diamedica Therapeutics Shares that will get you 0.2622 shares as per Diamedica Therapeutics share price of $5.72 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Diamedica Therapeutics Stock (DMAC) from India?
Indian investors can start investing in Diamedica Therapeutics (DMAC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Diamedica Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Diamedica Therapeutics share’s latest price of $5.72 as on August 30, 2025 at 1:29 am IST, you will get 1.7483 shares of Diamedica Therapeutics. Learn more about
fractional shares .
What are the returns that Diamedica Therapeutics has given to Indian investors in the last 5 years?
Diamedica Therapeutics stock has given 22.22% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%